Am J Dermatopathol

1. ISHIHARA Y, Ogita A, Ito K, Saeki H, et al
   Folliculosebaceous Cystic Hamartoma Arising in Miescher-Type Melanocytic Nevi.
   Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00083.
   

   >> Share

   
   
2. STICOVA E, Hugo J, Gkalpakiotis S
   Dermatitis Herpetiformis With Flame Figures-An Unusual Case Description.
   Am J Dermatopathol. 2022 Sep 7. pii: 00000372-990000000-00087.
   

   >> Share

   
   
3. MARK E, Sutton M, Gru A
   Primary Cutaneous Anaplastic Large-Cell Lymphoma With Aberrant CD20 Expression: Case Report and Review of the Literature.
   Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00081.
   

   >> Share

   
   
4. ZIPPERER K, Good AJ, Gibson BR, Goodwin B, et al
   Cutaneous Malignant Squamomelanocytic Tumor: A Case Report of a Rare Neoplasm.
   Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00080.
   

   >> Share

   
   
5. ROBBINS QC, Schmieg J, Rush WL, Allbritton JI, et al
   A Rare Case of Monomorphic T-Cell Posttransplant Lymphoproliferative Disorder Presenting as Primary Cutaneous Anaplastic Large Cell Lymphoma, ALK Negative.
   Am J Dermatopathol. 2022 Aug 9. pii: 00000372-990000000-00072.
   

   >> Share

   
   

   
   Am J Pathol

6. STUELTEN CH, Melis N, Subramanian B, Tang Y, et al
   Smurf2 regulates inflammation and collagen processing in cutaneous wound healing through TGF-beta/Smad3 signaling.
   Am J Pathol. 2022 Sep 2. pii: S0002-9440(22)00256.
   

   >> Share

   
   
7. WANG Y, Mack JA, Hascall VC, Maytin EV, et al
   TGFbetaR mediated, p38MAPK dependent signaling drives enhanced myofibroblast differentiation during skin wound healing in mice lacking hyaluronan synthases 1 and 3.
   Am J Pathol. 2022 Sep 2. pii: S0002-9440(22)00257.
   

   >> Share

   
   

   
   BMC Cancer

8. JIANG Y, Mason M, Cho Y, Chittiprolu A, et al
   Tolerance to oral anticancer agent treatment in older adults with cancer: a secondary analysis of data from electronic health records and a pilot study of patient-reported outcomes.
   BMC Cancer. 2022;22:950.
   

   >> Share

   
   
9. WANG Y, Lu R, Chen P, Cui R, et al
   Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.
   BMC Cancer. 2022;22:951.
   

   >> Share

   
   
10. PEPE FF, Cazzaniga ME, Baroni S, Riva F, et al
    Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 stu
    BMC Cancer. 2022;22:956.
    

    >> Share

    
    

    
    Br J Dermatol

11. KIM RW, Barta K, Begolka WS, Capozza K, et al
    The quantitative impact of atopic dermatitis on caregivers across multiple life domains.
    Br J Dermatol. 2022 Sep 3. doi: 10.1111/bjd.21855.
    

    >> Share

    
    
12. PUIG L
    Psoriasis treatment: no more room on the summit?
    Br J Dermatol. 2022 Sep 5. doi: 10.1111/bjd.21848.
    

    >> Share

    
    
13. HASAN ZU, Ahmed I, Matin RN, Homer V, et al
    Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Br J Dermatol. 2022;187:324-337.
    

    >> Share

    
    
14. FRITSCHE M, Okun M, Kirby JS
    Damage in hidradenitis suppurativa: a narrative review emphasizing the need for a novel outcome measure.
    Br J Dermatol. 2022;187:288-294.
    

    >> Share

    
    
15. CHEN F, Deng D, Pan C, Yao Z, et al
    Detection and characterization of low-level mosaicism among clinically unaffected parents of 'sporadic' epidermolysis bullosa simplex cases.
    Br J Dermatol. 2022;187:441-443.
    

    >> Share

    
    
16. JIANG SW, Kwock JT, Liu B, Petty AJ, et al
    High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.
    Br J Dermatol. 2022;187:417-419.
    

    >> Share

    
    
17. GRINNELL M, Keyes E, Diaz D, Vazquez T, et al
    Mycophenolate mofetil and methotrexate efficacy in dermatomyositis.
    Br J Dermatol. 2022;187:437-438.
    

    >> Share

    
    
18. KLEIN B, Treudler R, Dumann K, Boldt A, et al
    Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
    Br J Dermatol. 2022;187:419-422.
    

    >> Share

    
    
19. MERHI R, Canu D, Barnetche T, Duchez E, et al
    Assessment of Vitiligo Area Scoring Index (VASI), Facial-VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo.
    Br J Dermatol. 2022;187:422-424.
    

    >> Share

    
    
20. PENNITZ A, Kinberger M, Avila Valle G, Passeron T, et al
    Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
    Br J Dermatol. 2022;187:309-317.
    

    >> Share

    
    
21. DI CESARE A, Nikolakis G, Kanni T, Giamarellos-Bourboulis EJ, et al
    Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study.
    Br J Dermatol. 2022;187:428-430.
    

    >> Share

    
    
22. GARG A, Krueger JG
    Raising the bar for efficacy in hidradenitis suppurativa: a rationale for combination targeted therapies.
    Br J Dermatol. 2022;187:414-415.
    

    >> Share

    
    
23. CHANG R, Lai CC, Hung YM, Wang SI, et al
    Response to 'Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data'.
    Br J Dermatol. 2022;187:450.
    

    >> Share

    
    
24. FAZEL S, Paljarvi T
    Response to 'Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data': reply from authors.
    Br J Dermatol. 2022;187:450-451.
    

    >> Share

    
    
25. AARTS P, van der Zee HH
    Damage in hidradenitis suppurativa: receiving the deserved attention.
    Br J Dermatol. 2022;187:282-283.
    

    >> Share

    
    
26. GOULDEN V, Ling TC, Babakinejad P, Dawe R, et al
    British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022.
    Br J Dermatol. 2022;187:295-308.
    

    >> Share

    
    
27. PAVLOVSKY M, Peled A, Sarig O, Astman N, et al
    Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence.
    Br J Dermatol. 2022;187:392-400.
    

    >> Share

    
    
28. APFELBACHER C
    Closing a gap: an investigator global assessment for use in hidradenitis suppurativa clinical trials.
    Br J Dermatol. 2022;187:e79.
    

    >> Share

    
    

    
    Cancer

29. LEHRER S, Rheinstein PH
    Breast cancer and body weight changes of young women in the UK Biobank cohort.
    Cancer. 2022 Aug 9. doi: 10.1002/cncr.34423.
    

    >> Share

    
    
30. JACOBS JM, Post K, Massad K, Horick NK, et al
    A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.
    Cancer. 2022;128:3541-3551.
    

    >> Share

    
    
31. SOLDATO D, Havas J, Crane TE, Presti D, et al
    Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
    Cancer. 2022 Aug 1. doi: 10.1002/cncr.34401.
    

    >> Share

    
    
32. BARGON CA, Young-Afat DA, Ikinci M, Braakenburg A, et al
    Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis.
    Cancer. 2022 Jul 27. doi: 10.1002/cncr.34393.
    

    >> Share

    
    
33. SONDAK VK, Neves RI, Wuthrick EJ, Messina JL, et al
    Current and future approaches in the surgical management of T3b/T4 primary and locoregionally advanced melanoma.
    Cancer. 2022 Sep 6. doi: 10.1002/cncr.34449.
    

    >> Share

    
    

    
    Cancer Res

34. SRIVASTAVA A, Tommasi C, Sessions D, Mah A, et al
    MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.
    Cancer Res. 2022;82:3143-3157.
    

    >> Share

    
    

    
    Clin Dermatol

35. REHMAN S, Iqbal Z, Qureshi R, Rahman IU, et al
    Ethnic Practices in Treating Skin Diseases: The Traditional Dermatologist's Role.
    Clin Dermatol. 2022 Sep 4. pii: S0738-081X(22)00121.
    

    >> Share

    
    

    
    Eur J Dermatol

36. SILLER A JR, Tyring SK, Harter NN
    Infantile transient smooth muscle contraction of the skin
    Eur J Dermatol. 2022;32:431.
    

    >> Share

    
    
37. ANDRE R, Ram-Wolff C, Bagot M
    Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review
    Eur J Dermatol. 2022;32:421-423.
    

    >> Share

    
    
38. ALRASHDAN MS, Kamaguchi M
    Management of mucous membrane pemphigoid: a literature review and update
    Eur J Dermatol. 2022;32:312-321.
    

    >> Share

    
    
39. GUILLON C, Meziani M, Abdelli S, Sigaudo Roussel D, et al
    The aryl hydrocarbon receptor pathway plays a central role in the cutaneous response to pollutants
    Eur J Dermatol. 2022;32:305-311.
    

    >> Share

    
    
40. QIN H, Liu N, Hu Y, Yu N, et al
    Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study
    Eur J Dermatol. 2022;32:394-400.
    

    >> Share

    
    
41. JUZOT C, Isvy-Joubert A, Khammari A, Knol AC, et al
    Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma
    Eur J Dermatol. 2022;32:401-407.
    

    >> Share

    
    
42. REPOUSI N, Fotiadou S, Chaireti E, Makris G, et al
    Circadian cortisol profiles and hair cortisol concentration in patients with psoriasis: associations with anxiety, depressive symptomatology and disease severity
    Eur J Dermatol. 2022;32:357-367.
    

    >> Share

    
    
43. BARRE M, Amatore F, Avenin M, Gorvel L, et al
    Occurrence of Sezary syndrome following the initiation of anti-IL-5 treatment
    Eur J Dermatol. 2022;32:419-420.
    

    >> Share

    
    
44. KIMURA R, Sugita K, Horie T, Yamamoto O, et al
    Dual role of basophils in the pathogenesis of bullous pemphigoid elucidated by pathological and ultrastructural studies
    Eur J Dermatol. 2022;32:322-333.
    

    >> Share

    
    
45. PRUGNIT-ROUANET M, Delaumenie S, Couraud A, Audevard D, et al
    Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease
    Eur J Dermatol. 2022;32:368-372.
    

    >> Share

    
    
46. FUKUZONO M, Okiyama N, Iwasaki R, Endo R, et al
    Intravenous immunoglobulin-induced thrombocytopenia: a case report and review of the literature
    Eur J Dermatol. 2022;32:373-376.
    

    >> Share

    
    
47. VAZQUEZ-LOPEZ F, Carrero Martin J, Gomez de Castro C, Vivanco-Allende B, et al
    Spectrum of comorbid autoimmune diseases in patients with chondrodermatitis nodularis helicis: a 17-year retrospective study of 215 patients in Asturias, northern Spain
    Eur J Dermatol. 2022;32:347-351.
    

    >> Share

    
    
48. DOLEZALOVA K, Strachan T, Matej R, Ricna D, et al
    Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNgamma immunity
    Eur J Dermatol. 2022;32:1-10.
    

    >> Share

    
    
49. MORI S, Makino T, Shimizu T
    Localized cutaneous nodular amyloidosis associated with Sjogren's syndrome and thymoma
    Eur J Dermatol. 2022;32:408-410.
    

    >> Share

    
    
50. BAKLOUTI M, Sellami K, Turki H
    sQuiz your knowledge! Vesicles of the thighs weeping a milky white fluid
    Eur J Dermatol. 2022;32:432-433.
    

    >> Share

    
    
51. NAVARRO M, Le Helloco C, Leducq S
    sQUIZ your knowledge! Painful toe ulcers in a 79-year-old woman
    Eur J Dermatol. 2022;32:430.
    

    >> Share

    
    
52. REIS J, Nogueira M, Figueiras O, Coelho A, et al
    Pemphigus foliaceous after mRNA COVID-19 vaccine
    Eur J Dermatol. 2022;32:428-429.
    

    >> Share

    
    
53. FUJISHIMA C, Munemoto S, Hioki C, Sasaki H, et al
    Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
    Eur J Dermatol. 2022;32:416-417.
    

    >> Share

    
    
54. WATABE D, Tsunoda K, Amano H
    Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine
    Eur J Dermatol. 2022;32:420-421.
    

    >> Share

    
    
55. NAKAGAWA M, Hanada M, Amano H
    Allergic contact stomatitis caused by (meth)acrylates following sensitization by artificial nails, 20 years previously
    Eur J Dermatol. 2022;32:413-415.
    

    >> Share

    
    
56. ROLO DE MATOS P, Nogueira A, Gomes N, Costa C, et al
    Rare presentation of Wells syndrome mimicking angioedema: a case report
    Eur J Dermatol. 2022;32:411-413.
    

    >> Share

    
    
57. ULDAHL A, Sterner T, Bruze M, Dahlin J, et al
    Atopy patch testing and associations with atopic conditions and specific IgE tests: a population-based study in adolescents
    Eur J Dermatol. 2022;32:384-393.
    

    >> Share

    
    
58. TANEMURA A, Mori S, Tonomura K, Yokoi K, et al
    Successful hybrid grafting of autologous cultured epidermis carrying a revertant mutation and split mesh skin in a patient with recessive dystrophic epidermolysis bullosa
    Eur J Dermatol. 2022;32:417-419.
    

    >> Share

    
    
59. YANG L, Wang T, Liu YH
    A Chinese case of amelanotic lentigo maligna melanoma
    Eur J Dermatol. 2022;32:410-411.
    

    >> Share

    
    
60. DARLENSKI R, Cherkezov D, Bogdanov I
    Prolonged but not short exposure to the climate in Antarctica is associated with increased skin barrier permeability, erythema, and pigmentation
    Eur J Dermatol. 2022;32:334-337.
    

    >> Share

    
    

    
    Hum Mutat

61. XIA B, Biswas K, Foo TK, Gomes TT, et al
    Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.
    Hum Mutat. 2022;43:1396-1407.
    

    >> Share

    
    
62. PEREZ-BECERRIL C, Wallace AJ, Schlecht H, Bowers NL, et al
    Screening of potential novel candidate genes in schwannomatosis patients.
    Hum Mutat. 2022;43:1368-1376.
    

    >> Share

    
    

    
    Int J Dermatol

63. PARK A, Wong L, Lang A, Kraus C, et al
    Cutaneous T-cell lymphoma following dupilumab use: a systematic review.
    Int J Dermatol. 2022 Sep 8. doi: 10.1111/ijd.16388.
    

    >> Share

    
    
64. KUSSINI J, Charalambous A, Sachsenweger F, Steinert M, et al
    Successful removal of anthralin staining from facial skin.
    Int J Dermatol. 2022 Sep 8. doi: 10.1111/ijd.16405.
    

    >> Share

    
    

    
    Intern Med

65. MORIMOTO T, Yamasaki K, Isoshima Y, Yatera K, et al
    Avelumab-induced Pneumonitis in Metastatic Merkel Cell Carcinoma.
    Intern Med. 2022;61:2697-2698.
    

    >> Share

    
    
66. SHINZAWA T, Usui I, Hanawa K, Kajitani H, et al
    Acute Exacerbation of Anemia with Parvovirus B19 Infection One Year after Sleeve Gastrectomy for Severe Obesity.
    Intern Med. 2022;61:2631-2635.
    

    >> Share

    
    
67. ADACHI-KATAYAMA M, Kondo Y, Okamoto S, Sato R, et al
    Synovitis-acne-pustulosis-hyperostosis-osteitis Syndrome with Bilateral Pleural Effusion.
    Intern Med. 2022;61:2671-2675.
    

    >> Share

    
    
68. SHIMAZAKI R, Sugaya K
    Difference between the MRI Findings for Neuro-Behcet Disease and Neuro-Sweet Disease.
    Intern Med. 2022;61:2701.
    

    >> Share

    
    

    
    J Cutan Pathol

69. KITZ R, Leung O, Royer M
    A Rapidly Growing Cutaneous Malignant Glomus Tumor with a CCND3 Mutation.
    J Cutan Pathol. 2022 Sep 4. doi: 10.1111/cup.14324.
    

    >> Share

    
    
70. SAUVAGEAU AP, Oulee A, Huang YY, Patel RM, et al
    Cutaneous Sarcoidosis Mimicking Pigmented Purpuric Dermatosis.
    J Cutan Pathol. 2022 Sep 7. doi: 10.1111/cup.14326.
    

    >> Share

    
    

    
    J Dermatol

71. HIRATA Y, Shiiya C, Miyamoto J, Saito M, et al
    Congenital curved nail of the fourth toe: Report of three cases and review of the literature.
    J Dermatol. 2022;49:925-927.
    

    >> Share

    
    
72. LEEYAPHAN C, Nanchaipruek Y, Phinyo P
    Therapeutic outcomes and prognostic factors in patients with hypertrophic herpes simplex infection treated with imiquimod: A systematic review and meta-analysis of individual patient data from case reports and case series.
    J Dermatol. 2022;49:879-886.
    

    >> Share

    
    
73. TORII H, Kishimoto M, Tanaka M, Noguchi H, et al
    Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.
    J Dermatol. 2022;49:818-828.
    

    >> Share

    
    
74. JAWORSKA K, Slawinska M, Wyszomirski A, Lakomy J, et al
    Dermoscopic features of eyelid margin tumors: A single-center retrospective study.
    J Dermatol. 2022;49:851-861.
    

    >> Share

    
    
75. HUANG L, Zhang J, Chen F, Zhang X, et al
    The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    J Dermatol. 2022;49:921-924.
    

    >> Share

    
    
76. CHAO YC, Hong JB, Liu C, Lee MS, et al
    COL7A1 G2287R mutation with two clinical phenotypes in the same family: Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa.
    J Dermatol. 2022;49:e313-e314.
    

    >> Share

    
    
77. MIZUMAKI K, Makino S, Ikawa Y, Maeda S, et al
    Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-gamma antibody.
    J Dermatol. 2022;49:e311-e312.
    

    >> Share

    
    
78. TAKAMURA S, Teraki Y
    Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines.
    J Dermatol. 2022;49:845-850.
    

    >> Share

    
    
79. SHIBATA Y, Fukuda T, Nobeyama Y, Asahina A, et al
    Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: Chest CT imaging for screening purposes.
    J Dermatol. 2022 Sep 8. doi: 10.1111/1346-8138.16564.
    

    >> Share

    
    

    
    J Invest Dermatol

80. ZHU R, Yang H, Xue S, Fan Q, et al
    Intervening GSK3 Signaling Attenuates Cutaneous Inflammation and Itch in Mice: Implication for Future Therapeutic Development.
    J Invest Dermatol. 2022 Sep 1. pii: S0022-202X(22)01889.
    

    >> Share

    
    
81. LASHERAS-OTERO I, Feliu I, Maillo A, Moreno H, et al
    The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma.
    J Invest Dermatol. 2022 Sep 1. pii: S0022-202X(22)01890.
    

    >> Share

    
    
82. AGELOPOULOS K, Renkhold L, Wiegmann H, Dugas M, et al
    Transcriptomic, epigenomic and neuro-anatomic signatures differ in chronic prurigo, atopic dermatitis and brachioradial pruritus.
    J Invest Dermatol. 2022 Sep 5. pii: S0022-202X(22)01895.
    

    >> Share

    
    

    
    N Engl J Med

83. LANG DM
    Chronic Urticaria.
    N Engl J Med. 2022;387:824-831.
    

    >> Share

    
    
84. CHRISTIAN NT, Borges VF
    What Dobbs Means for Patients with Breast Cancer.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2209249.
    

    >> Share

    
    

    
    Plast Reconstr Surg

85. MOELLHOFF N, Lettner M, Frank K, Giunta RE, et al
    Use of polylactid acid membrane improves outcome of split-thickness skin graft donor sites: a prospective, comparative, randomized study.
    Plast Reconstr Surg. 2022 Sep 1. pii: 00006534-990000000-01099.
    

    >> Share

    
    

    
    PLoS One

86. VICENTE-MUNOZ S, Hunt BG, Lange TE, Wells SI, et al
    NMR-based metabolomic analysis identifies RON-DEK-beta-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
    PLoS One. 2022;17:e0274128.
    

    >> Share

    
    
87. RODARI G, Guez S, Salera S, Ulivieri FM, et al
    A single-centre study on predictors and determinants of pubertal delay and growth impairment in Epidermolysis Bullosa.
    PLoS One. 2022;17:e0274072.
    

    >> Share

    
    
88. IWAI T, Hoshi M, Oebisu N, Takada N, et al
    Tumor-skin invasion is a reliable risk factor for poor prognosis in superficial soft tissue sarcomas.
    PLoS One. 2022;17:e0274077.
    

    >> Share

    
    
89. PEREIRA ICF, Wyss HM, Pinchuk L, Beckers HJM, et al
    A model for designing intraocular pressure-regulating glaucoma implants.
    PLoS One. 2022;17:e0273672.
    

    >> Share

    
    
90. BECKER JM, Holle H, van Ryckeghem DML, Van Damme S, et al
    No preconscious attentional bias towards itch in healthy individuals.
    PLoS One. 2022;17:e0273581.
    

    >> Share

    
    
91. LI D, Li J, Yuan Y, Zhou J, et al
    Risk factors and prognosis of acute lactation mastitis developing into a breast abscess: A retrospective longitudinal study in China.
    PLoS One. 2022;17:e0273967.
    

    >> Share

    
    
92. VAN GOGH S, Mukherjee S, Xu J, Wang Z, et al
    Iterative phase contrast CT reconstruction with novel tomographic operator and data-driven prior.
    PLoS One. 2022;17:e0272963.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share